# Study With Phage for CF Subjects With Pseudomonas Lung Infection

> **NCT06998043** · PHASE2 · RECRUITING · sponsor: **BiomX Ltd** · enrollment: 63 (estimated)

## Conditions studied

- Chronic Pseudomonas Aeruginosa Infection
- Cystic Fibrosis (CF)

## Interventions

- **BIOLOGICAL:** BX004
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06998043
- **Lead sponsor:** BiomX Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-02
- **Primary completion:** 2026-03
- **Final completion:** 2026-09
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06998043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06998043, "Study With Phage for CF Subjects With Pseudomonas Lung Infection". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06998043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*